Upgrade to SI Premium - Free Trial

Abbvie (ABBV) PT Raised to $288 at Guggenheim

August 4, 2026 6:49 AM
(Updated - August 4, 2026 6:55 AM EDT)

Guggenheim analyst Vamil Divan raised the price target on Abbvie (NYSE ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change